In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

459 News Items found
Q&A
medical oncologist Larry Norton
Definitive Proof that Dose-Dense Chemotherapy Is Safe and Effective for Breast Cancer

Dose-dense chemotherapy calls for less time between doses compared with a standard treatment plan.
MSK breast cancer patient Kéara Richardson
How Chemotherapy Before Breast Cancer Surgery Preserved Kéara’s Quality of Life

Learn how Kéara was able to maintain her quality of life after treatment for triple negative breast cancer.
Q&A
medical oncologist Larry Norton
Some Women with Early Breast Cancer May Not Need Chemotherapy, Study Says

The findings will change how women with intermediate-risk breast cancer are treated.
Q&A
Molecular model of olaparib
The Latest on Genetic Testing for BRCA Mutations in Breast Cancer

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.
A woman receives a mammogram, and two technicians help her.
Shorter Version of MRI Plays New Role in Breast Cancer Detection

Researchers from Memorial Sloan Kettering Cancer Center (MSK), in collaboration with an international research team and the ECOG-ACRIN Cancer Research Group, have found that abbreviated breast magnetic resonance imaging (MRI) detected more cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breast tissue.
In the Clinic
MSK patient receiving chemotherapy
6 Breakthroughs That Are Changing Chemotherapy for People with Breast Cancer

Discover some of the latest innovations in chemotherapy for breast cancer.
Breast cancer patient Mikaela Rix
Mikaela’s Story: Facing Breast Cancer as a Woman in Her 20s

Former college lacrosse player Mikaela Rix, diagnosed at age 26, accessed a wide range of resources offered by MSK’s new program tailored for young women with breast cancer.
Dr. Colleen McCarthy
Patient Information Sessions Focus on Breast Cancer in October

In honor of Breast Cancer Awareness Month in October, Memorial Sloan Kettering (MSK) held two Information Sessions for breast cancer patients, caregivers, and those at increased risk for the disease.
Feature
A woman considering birth control pills
Birth Control and Cancer Risk: 6 Things You Should Know

Find out what an MSK gynecologist thinks you should know about birth control and cancer risk.
Finding
MSK Physician-in-Chief José Baselga presents at the ASCO meeting
Targeted Therapy Slows Growth of Most Common Type of Advanced Breast Cancer

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.